xenitra.com | ASX: XEN | ACN: 150 110 017 | 270 Adelaide St, Brisbane 4000 ASX Announcement 30 July 2026 Xenitra Limited (ASX:XEN) (Xenitra or the Company) is pleased to provide its operational update and Appendix 4C quarterly cashflow report for the...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Xenitra
- Investor Webinar
- $12M offtake agreement with leading OTC-pharmaceutical
- $1.1m in OPAL-Tokenised Product Sales in First 7 Weeks
- XEN Appointed as Exclusive Biomiq Skincare China Distributor
- Product sales of $500k in first month of OPAL token launch
Later from Xenitra
- Investor Presentation
- $5m Offtake Agreement Expands OTC-Medicine Business
- Trading Halt
- Proposed issue of securities - XEN
- Xenitra Raises $1.5m to Accelerate High-Margin Sales Growth
Follow Xenitra into a list and get an email when it puts out news.
Follow Xenitra